Treatment options for ocular adnexal lymphoma (OAL)

Victoria Mary Lendrum CohenSt. Bartholomew’s and Moorfields Eye Hospital, London UKAbstract: Most lymphomas that involve the ocular adnexal structure are low grade, B cell, non-Hodgkin’s lymphomas. The treatment depends upon the grade and stage of the disease. High grade...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Victoria Mary Lendrum Cohen
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/23b8a8915fa0492280ac1150bbb5653d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:23b8a8915fa0492280ac1150bbb5653d
record_format dspace
spelling oai:doaj.org-article:23b8a8915fa0492280ac1150bbb5653d2021-12-02T00:27:24ZTreatment options for ocular adnexal lymphoma (OAL)1177-54671177-5483https://doaj.org/article/23b8a8915fa0492280ac1150bbb5653d2009-11-01T00:00:00Zhttp://www.dovepress.com/treatment-options-for-ocular-adnexal-lymphoma-oal-a3772https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Victoria Mary Lendrum CohenSt. Bartholomew’s and Moorfields Eye Hospital, London UKAbstract: Most lymphomas that involve the ocular adnexal structure are low grade, B cell, non-Hodgkin’s lymphomas. The treatment depends upon the grade and stage of the disease. High grade lymhoma requires treatment with systemic chemotherapy whereas the localized low grade (extranodal marginal zone lymphoma) can be successfully managed with local radiotherapy. Chlamydia psittaci infection is associated with low grade ocular lymphoma; however there is wide geographic variation in the strength of this association. Blanket antibiotic therapy is not advised unless there is proof of an infective agent. The monoclonal antibody, rituximab, may be successful for CD20 positive lymphoma, although it is likely that rituximab will have better long-term results when used in combination with systemic chemotherapy.Keywords: ocular adnexal lymphoma, mucosa associated lymphoid tissue, extranodal marginal zone lymphoma, Chlamydia psittaci, rituximab, radiotherapy, chemotherapy Victoria Mary Lendrum CohenDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2009, Iss default, Pp 689-692 (2009)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Victoria Mary Lendrum Cohen
Treatment options for ocular adnexal lymphoma (OAL)
description Victoria Mary Lendrum CohenSt. Bartholomew’s and Moorfields Eye Hospital, London UKAbstract: Most lymphomas that involve the ocular adnexal structure are low grade, B cell, non-Hodgkin’s lymphomas. The treatment depends upon the grade and stage of the disease. High grade lymhoma requires treatment with systemic chemotherapy whereas the localized low grade (extranodal marginal zone lymphoma) can be successfully managed with local radiotherapy. Chlamydia psittaci infection is associated with low grade ocular lymphoma; however there is wide geographic variation in the strength of this association. Blanket antibiotic therapy is not advised unless there is proof of an infective agent. The monoclonal antibody, rituximab, may be successful for CD20 positive lymphoma, although it is likely that rituximab will have better long-term results when used in combination with systemic chemotherapy.Keywords: ocular adnexal lymphoma, mucosa associated lymphoid tissue, extranodal marginal zone lymphoma, Chlamydia psittaci, rituximab, radiotherapy, chemotherapy
format article
author Victoria Mary Lendrum Cohen
author_facet Victoria Mary Lendrum Cohen
author_sort Victoria Mary Lendrum Cohen
title Treatment options for ocular adnexal lymphoma (OAL)
title_short Treatment options for ocular adnexal lymphoma (OAL)
title_full Treatment options for ocular adnexal lymphoma (OAL)
title_fullStr Treatment options for ocular adnexal lymphoma (OAL)
title_full_unstemmed Treatment options for ocular adnexal lymphoma (OAL)
title_sort treatment options for ocular adnexal lymphoma (oal)
publisher Dove Medical Press
publishDate 2009
url https://doaj.org/article/23b8a8915fa0492280ac1150bbb5653d
work_keys_str_mv AT victoriamarylendrumcohen treatmentoptionsforocularadnexallymphomaoal
_version_ 1718403728047865856